Skip to Content

Join the 'Ophthalmic Surgery' group to help and get support from people like you.

Ophthalmic Surgery News

Paintball Causes Many Vision-Robbing Eye Injuries

Posted 3 Nov 2016 by Drugs.com

THURSDAY, Nov. 4, 2016 – Paintball guns pose the greatest risk of vision loss among the sports most commonly associated with eye injuries, a new study finds. Basketball, cycling and baseball injuries to the eye occur more often than paintball-related eye accidents. But the popular air guns are far more likely to impair sight when an eye injury occurs, at least in the short term, researchers say. The findings emphasize the importance of eye protection, said Dr. Matthew Gardiner, director of emergency ophthalmology services at Massachusetts Eye and Ear in Boston. "It's important to be aware of the threat to vision in these activities and wear safety glasses," said Gardiner, who wasn't involved in the study. "Simple preventive measures can solve almost all these problems." The new report is the most extensive analysis of its kind, said lead author Dr. R. Sterling Haring, a research fellow ... Read more

Related support groups: Eye Conditions, Retinal Disorders, Ophthalmic Surgery, Visual Defect/Disturbance

Cornea Transplants Riskier for Women When They Come From Men?

Posted 15 Jul 2016 by Drugs.com

FRIDAY, July 15, 2016 – Women who undergo a cornea transplant may have a worse outcome if their donor is a man, a new study suggests. Subtle differences between men and women may increase the risk of failure or rejection for up to five years, the British researchers found. They noted that matching the gender of cornea donors and recipients could help improve transplant outcomes. The study involved more than 18,100 cornea transplant patients. More than 80 percent still had a working cornea after five years. Of those who had a failed transplant or tissue rejection, more were women who had received a cornea from a male donor. On average, 180 transplants fail for every 1,000 gender-matched procedures, compared with 220 failures among every 1,000 male-to-female transplants, according to the researchers. They said these results were especially evident among patients with Fuchs endothelial ... Read more

Related support groups: Surgery, Eye Conditions, Cataract, Corneal Ulcer, Corneal Abrasion, Ophthalmic Surgery, Visual Defect/Disturbance, Corneal Refractive Surgery

Music Soothes Nervous Eye Surgery Patients

Posted 29 May 2016 by Drugs.com

FRIDAY, May 27, 2016 – Listening to relaxing music before eye surgery reduces patients' anxiety and their need for sedation, a new French study suggests. "Music listening may be considered as an inexpensive, noninvasive, non-pharmacological method to reduce anxiety for patients undergoing elective eye surgery under local anaesthesia," said lead researcher Dr. Gilles Guerrier, from Cochin University Hospital in Paris. The study included 62 people who had outpatient cataract surgery while awake and under local anesthesia. The surgery lasted an average of 15 minutes. Some patients listened to relaxing music through headphones for about 15 minutes before their surgery, while others did not. Those who listened to music could choose from 16 styles, such as jazz, flamenco, Cuban, classical and piano. Compared with those who did not listen to music, patients in the music group had much lower ... Read more

Related support groups: Anxiety, Anxiety and Stress, Eye Conditions, Cataract, Ophthalmic Surgery, Myopia, Ophthalmic Surgical Staining, Corneal Refractive Surgery

Using Same Hospital for Complications After Surgery Lowers Death Risk: Study

Posted 18 Jun 2015 by Drugs.com

THURSDAY, June 18, 2015 – Surgery patients who suffer complications after discharge from a hospital are more likely to die if they're readmitted to a different hospital than where they had their original operation, a new study finds. University of Utah researchers reviewed information on millions of Medicare patients who underwent one of 12 major surgical procedures between 2001 and 2011. They found that up to one-fifth of the patients were readmitted to a hospital within 30 days due to complications. Up to 83 percent of patients with complications were readmitted to the same hospital where they had their initial surgery. Overall, readmission to the same hospital was associated with a 26 percent lower risk of death within 90 days, the study revealed. For specific types of surgeries, the risk of death associated with readmission to the same hospital ranged from 44 percent lower for ... Read more

Related support groups: Surgery, Hip Replacement, Knee Joint Replacement, Gastric Bypass Surgery, Orthopedic Surgery, Head & Neck Surgery, Neurosurgery, Appendectomy, Ophthalmic Surgery, Gastrointestinal Surgery, Spleen Removal, Vascular Surgery, Cardiothoracic Surgery, Genitourinary Surgical and Other Conditions

FDA Approves Omidria for Use in Cataract and Other Intraocular Lens Replacement Procedures

Posted 9 Jun 2014 by Drugs.com

SEATTLE, June 2, 2014 /PRNewswire/ – Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved Omidria (phenylephrine and ketorolac injection) 1%/0.3% for use during cataract surgery or intraocular lens replacement (ILR) to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative pain. The approval comes with no post-marketing commitments other than the previously agreed study of Omidria for use in pediatric patients, which, if successfully completed, makes the drug eligible for an additional six months of marketing exclusivity in the U.S. Omidria, the first commercial product from Omeros' PharmacoSurgery® platform, is a proprietary combination of a mydriatic (pupil-dilating) agent and an anti-inflammatory agent that is added to irrigation solution standardly used during cataract ... Read more

Related support groups: Ophthalmic Surgery

ReSure Sealant Gel Approved for Eye Surgery

Posted 10 Jan 2014 by Drugs.com

FRIDAY, Jan. 10, 2014 – A sealant gel to prevent fluid leakage after cataract surgery has been approved by the U.S. Food and Drug Administration. While gels such as ReSure have been approved to seal small incisions in other parts of the body, this is the first such approval for the eye, the agency said in a news release. A cataract is a gradual clouding of the eye's lens. By age 80, more than half of Americans have either an active cataract or have had cataract surgery, the U.S. National Institutes of Health estimates. The ReSure Sealant kit includes two liquid solutions that are mixed together just before use. The product is designed to seal an eye incision within 20 seconds of application, the FDA said. The gel then breaks down over seven days and is naturally flushed away by the eye's tears. No serious adverse reactions to the gel were reported, the FDA said. Before this approval, ... Read more

Related support groups: Ophthalmic Surgery

FDA Medwatch Alert: Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile

Posted 11 Jan 2013 by Drugs.com

ISSUE: Mobius Therapeutics announced that it is conducting a voluntary recall of 2 lots of Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use. The company cannot exclude the possibility that the affected lots may be non-sterile.These two lots of Mitosol (mitomycin for solution) Kits may contain a strain of yeast on one or more parts in the kit and should be considered non-sterile and unsafe for use. Use of these products could result in serious eye problems/infections, including possible blindness. BACKGROUND:  The Mitosol Kit for Opthalmic Use is an antimetabolite indicated as an adjunct to glaucoma surgery. The recalled lot numbers and a list of the 20 states to which the product was distributed are listed in the firm press release. The recalled product was distributed between 10/22/2012 and 12/14/2012. Mobius has not received any report of adverse events related to ... Read more

Related support groups: Ophthalmic Surgery, Mitomycin Ophthalmic, Mitosol

Cataract Patients Relax to a Soothing Beat, Study Says

Posted 12 Nov 2012 by Drugs.com

MONDAY, Nov. 12 – Playing soothing sounds during cataract surgery reduces patients' anxiety, according to a new study. Researchers assessed the effects of binaural beat audio therapy, which consists of two tones that are each pitched at a specific, slightly different frequency. Each tone is delivered to a separate ear via headphones. This technique triggers alpha-frequency brainwaves, which are linked to relaxation and reduced perception of fear and pain, the researchers say. For the study, the researchers divided about 140 cataract surgery patients into three groups. One group listened to binaural beats mixed with soothing music and nature sounds, another group listened to music only, and a control group did not receive any audio therapy. Patients who listened to the binaural beats/music mix before, during and after cataract surgery had less anxiety and a slower heart rate than those ... Read more

Related support groups: Cataract, Ophthalmic Surgery

Cataract Surgery May Cut Risk of Hip Fracture

Posted 31 Jul 2012 by Drugs.com

TUESDAY, July 31 – Cataract surgery may help some senior citizens reduce their risk of fall-related hip fractures, a new study suggests. A cataract is a clouding of the eye's lens; symptoms can include blurry vision, glare and poor night vision. As a result, people with cataracts may be more prone to falls. In the new study, individuals aged 65 or older who had cataract surgery were less likely to sustain a hip fracture within a year of the procedure when compared with their peers who did not have the surgery. Researchers analyzed Medicare claims data, but they did not have access to information on falls. Their findings appear in the Aug. 1 issue of the Journal of the American Medical Association. Reduction in risk for hip fractures may help tip the scale in favor of cataract surgery, said study author Dr. Anne Coleman, professor of ophthalmology at the Jules Stein Eye Institute at the ... Read more

Related support groups: Cataract, Fracture, bone, Ophthalmic Surgery

FDA Medwatch Alert: Brilliant Blue G: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases

Posted 19 Mar 2012 by Drugs.com

ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgeries. Clinicians in several states reported the adverse events. FDA, along with CDC and local and state public health agencies, are actively investigating these adverse events. BACKGROUND: The BBG was supplied by Franck’s Compounding Lab, Ocala, Florida. Franck’s Pharmacy issued a recall on March 9, 2012, of all lots of Brilliant Blue G and issued a recall letter (link below). Brilliant Blue G is not an approved drug in the U.S.  RECOMMENDATION: Immediately quarantine and return any remaining Brilliant Blue G product. This includes all lots of Brilliant Blue G received from Franck’s Pharmacy. FDA requests that practitioners report to MedWatch any cases of endophthalmitis, fungal or bacterial, that occurred within the last six months, associated with ... Read more

Related support groups: Ophthalmic Surgery

Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

Posted 9 Feb 2012 by Drugs.com

ST. LOUIS, Feb. 9, 2012 /PRNewswire/ – Mobius Therapeutics, LLC, a St. Louis-based ophthalmic company, has received final approval from the U.S. Food and Drug Administration for the platform product, Mitosol. This initial indication is for the use of Mitosol in glaucoma surgery. With FDA approval, Mobius Therapeutics can start marketing and production efforts for Mitosol immediately. "The approval of Mitosol for use in glaucoma surgery represents the culmination of more than five years of work on the part of Mobius Therapeutics," said Ed Timm, President of Mobius Therapeutics. "It will provide surgeons, hospitals, and patients with enhanced convenience, safety, and consistency in the surgical treatment of glaucoma." Glaucoma is the second-leading cause of blindness in the United States. It is treated progressively, beginning with pharmaceuticals, then office intervention and finally ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Ophthalmic Surgery, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Eye Condition May Alter Corneal Transplant Results

Posted 1 Jul 2010 by Drugs.com

THURSDAY, July 1 – Corneal transplant rejection is more likely to occur in people who have abnormal vessel growth in their eyes before undergoing the surgery, a team of German and British researchers reports. However, people with the condition – known as neovascularization – might improve their chances of a successful transplant, the researchers say, if they were given growth-inhibiting drugs beforehand. Known as antiangiogenics, such drugs include bevacizumab and ranibizumab. In addition, other drugs that work at the genetic level to control such problematic growth are currently under study. "The presence of corneal neovascularization before surgery makes it about 30 percent more likely that the transplant will fail and more than doubles the risk of graft rejection," researcher Dr. Claus Cursiefen said in a news release from the American Academy of Ophthalmology. "We also found that ... Read more

Related support groups: Ophthalmic Surgery

Ask a Question

Further Information

Related Condition Support Groups

Postoperative Ocular Inflammation, Corneal Refractive Surgery, Ophthalmic Viscoelastic Agent, Ophthalmic Surgical Staining, Surgery

Related Drug Support Groups

Vigamox, Zymar, proparacaine, Ocuflox, Besivance, Ciloxan, besifloxacin, Ocu-Caine, Akten, view more... BSS Plus, Endosol Extra, Navstel, Parcaine, Omidria, Alcaine, ophthalmic irrigation, intraocular ophthalmic, ketorolac / phenylephrine, Quixin, Iquix, Ophthaine, Ophthetic, AK-Taine